After having published 320 scientific papers, Conicet researcher Gabriel Rabinovich founded a technology-based company (Galtec / Conicet)
It may interest you: How artificial intelligence and predictive algorithms are revolutionizing oncology
In 1993 Rabinovich described the function of a protein, called galectin -1, in the immune system of an organism complex / Galtec / Conicet
It may interest you: What is Galtec, the first biotechnological start-up against cancer created by an Argentine scientist who is on his way to the Nobel Prize
One of the products that the new company will develop will focus on colorectal cancer (Getty)
It may interest you: Detection of a new class of molecules could revolutionize cancer treatment
Rabinovich presented the Galtec company in society, with the presence of the Minister of Science, Technology and Innovation, Daniel Filmus, and the president of Conicet, Ana Franchi/ Maxi Luna
In 2014, Rabinovich and his team tested in experimental models that the protein Galectin -1 helps different types of cancers escape the immune response and creates blood vessels that allow tumors to obtain oxygen and nutrients to grow and metastasize/ Galtec / Conicet
As part of the potential therapies, an antibody will be investigated that could act against the creation of blood vessels in tumors and modulate the immune system so that it can eliminate tumor cells / File
The technology-based company will also focus on products for multiple sclerosis, a disease that can cause motor disability in some patients/File
At the launch of the company, Rabinovich spoke with Minister Filmus and the director of the IBYME of the Conicet, Victoria Lux/ Maxi Luna
What is Galtec, the first biotechnological start-up against cancer created by an Argentine scientist who is on his way to the Nobel Prize
From cancer and sepsis to COVID-19: the various functions of galectin 1, a key protein in the human body
Scientists from Argentina discover key circuits of the immune system in the intestine
The science of sugars: the Argentine contribution that goes from the Nobel Prize Leloir to Gabriel Rabinovich
